Does WHOOP’s biomarker integration move wearables closer to regulated healthcare?
WHOOP launches Advanced Labs in the UAE with Unilabs, integrating 65 biomarkers into its wearable platform. Explore what this shift means.
Is immune status the next wellness frontier? Inside Kirin and Immunosens’s strategy
Kirin and Immunosens are developing a urinary IgA self-testing service to visualize immune status. Find out what this changes for consumer immune monitoring.
What SCIEX’s Echo MS+ compatibility with ZenoTOF 8600 signals for modern drug discovery labs
SCIEX integrates Echo MS+ with ZenoTOF 8600 to reshape high-throughput mass spectrometry workflows. Find out why this matters for discovery labs.
Could Carterra Inc.’s Vega HT-SPR accelerate fragment and small-molecule discovery without compromising rigor
Find out how Carterra Inc.’s Vega HT-SPR platform could redefine primary screening and reshape early drug discovery workflows.
TRUE METRIX labeling change puts focus on how glucose meters communicate extreme-risk events
Trividia Health, Inc. has initiated a labeling correction for all TRUE METRIX blood glucose monitoring systems to update how the E-5 error code is described in owner booklets and instructions for use across multiple international markets. The change clarifies that users experiencing symptoms of high blood glucose alongside an E-5 reading must seek immediate medical […]
Rapid Medical’s DISTALS trial signals a structural shift in how medium vessel stroke may finally be treated
Rapid Medical disclosed late-breaking results from its DISTALS randomized controlled trial showing that the TIGERTRIEVER 13 thrombectomy device achieved significantly higher tissue reperfusion without symptomatic intracranial hemorrhage compared with medical management in medium vessel occlusion stroke. The data were presented at the 2026 International Stroke Conference and form the basis for a planned United States […]
Johnson & Johnson’s early OMNYPULSE data show promise, but the real test lies ahead
Johnson & Johnson has presented 12-month pilot data from the OMNY-AF study evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation at the 2026 AF Symposium. The early pilot cohort reported high acute procedural success, no procedure-related adverse events, and a 12-month freedom from atrial fibrillation rate approaching 90 percent. The […]
NMPA greenlights ZEISS ARTEVO 750 and 850, boosting China’s surgical visualization tech
ZEISS receives NMPA approval in China for ARTEVO 750 and 850 ophthalmic microscopes. Find out how these devices are shaping the future of eye surgery.
Why FUGO’s integrated printing cycle could shift dental manufacturing economics
FUGO Precision 3D is debuting its centrifugal 3D printing tech at LMT LAB DAY 2026. Find out how this could transform dental manufacturing workflows.
Trace Biosciences’ LGW16-03 IND approval opens new chapter in nerve-targeted surgical imaging
Trace Biosciences receives IND approval for LGW16-03. Find out what this means for nerve imaging and the future of surgical precision.